Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ResMed Inc (RMD)

  • Business News
  • June 10, 2025, 22:36 UTC
  • 8

New SEC Form for ResMed Inc.

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • June 10, 2025, 22:34 UTC
  • 9

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

PepGen Inc. (PEPG)

  • Business News
  • June 10, 2025, 22:27 UTC
  • 8

Shareholder Alert: Robbins LLP Informs Investors of the PepGen Inc. Class Action

Market reaction Comment Full text

ArgenX Inc (ARGX)

  • Business News
  • June 10, 2025, 22:01 UTC
  • 8

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

Market reaction Comment Full text

Celularity Inc. (CELUW)

  • Business News
  • June 10, 2025, 21:19 UTC
  • 10

Celularity Announces Chief Financial Officer Transition

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 10, 2025, 21:02 UTC
  • 8

Is Your Device Or Browser Running Slow? Do This To Get It Back Up To Speed

Market reaction Comment Full text

Acadia Healthcare Company Inc (ACHC)

  • Business News
  • June 10, 2025, 21:00 UTC
  • 10

Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ACHC

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 10, 2025, 20:56 UTC
  • 8

The Best Tips for Making Windows 11 Look More Like Windows 10

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • June 10, 2025, 20:52 UTC
  • 9

Johnson & Johnson - Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • June 10, 2025, 20:51 UTC
  • 6

Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

Market reaction Comment Full text
  • Previous
  • 258
  • 259
  • 260
  • 261
  • 262
  • Next

Search

News categories

  • Technical Exchange News(9543)
  • Event(407)
  • SEC News(156366)
  • FDA Approval(8929)
  • Company Report(721)
  • Business News(106174)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin